504-02-9
Chemical Structure
Cyclohexane-1,3-dione
- CAS. Nr.: 504-02-9
- Formula:C6H8O2
- Molecular Weight:112.13
IUPAC Name: cyclohexane-1,3-dione
InChIKey: HJSLFCCWAKVHIW-UHFFFAOYSA-N
SMILES: O=C1CC(CCC1)=O
Biological Activity: Cyclohexane-1,3-dione is a drug intermediate, and its derivatives can exhibit significant tyrosine kinase inhibitory activity and anti-tumor activity[1][2].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cyclohexane-1,3-dione | 99.99% | Cyclohexane-1,3-dione is a drug intermediate, and its derivatives can exhibit significant tyrosine kinase inhibitory activity and anti-tumor activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cyclohexane-1,3-dione-13C3 | Cyclohexane-1,3-dione-13C3 is the 13C-labeled Cyclohexane-1,3-dione (HY-W007466). Cyclohexane-1,3-dione is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cyclohexane-1,3-dione-13C6 | Cyclohexane-1,3-dione-13C6 is the 13C-labeled Cyclohexane-1,3-dione (HY-W007466). Cyclohexane-1,3-dione is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.94
HY-W002860Cycloheptane-1,3-dione -
Similarity Score 0.93
HY-753551,3-Cyclopentanedione -
Similarity Score 0.90
HY-W0105541,4-Cyclohexanedione -
Similarity Score 0.86
HY-W007347R1,2-Cyclohexanedione (Standard) -
Similarity Score 0.79
HY-W0187782-Methyl-1,3-cyclohexanedione -
Similarity Score 0.78
HY-W0276902-Bromo-cyclohexane-1,3-dione -
Similarity Score 0.77
HY-W015740Dimedone -
Similarity Score 0.77
HY-76487Tetrahydro-4H-pyran-4-one -
Explore the MedChemAI to find more analogs
References
- [1]. Daoui O, et al. Cyclohexane-1,3-dione Derivatives as Future Therapeutic Agents for NSCLC: QSAR Modeling, In Silico ADME-Tox Properties, and Structure-Based Drug Designing Approach. ACS Omega. 2023 Jan 19;8(4):4294-4319. [Content Brief]
- [2]. Megally Abdo NY, et al. Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors. Bioorg Chem. 2020 Apr;97:103667. [Content Brief]